Alessandro Romanel Selected Research

Alessandro Romanel Research Topics

Disease

25	Neoplasms (Cancer) 03/2024 - 08/2014
14	Prostatic Neoplasms (Prostate Cancer) 03/2024 - 04/2013
3	Neoplasm Metastasis (Metastasis) 01/2022 - 01/2019
2	Inflammation (Inflammations) 03/2024 - 02/2024
2	Glioma (Gliomas) 01/2023 - 01/2022
2	Disease Progression 05/2019 - 09/2014
1	Rhabdomyosarcoma 01/2023
1	Ewing Sarcoma (Sarcoma, Ewing) 01/2023
1	Osteosarcoma (Osteogenic Sarcoma) 01/2023
1	X-Linked Bulbo-Spinal Atrophy 01/2023
1	Sarcoma (Soft Tissue Sarcoma) 01/2023
1	Pleural Effusion (Pleural Effusions) 02/2022
1	Brain Neoplasms (Brain Tumor) 01/2022
1	Thrombosis (Thrombus) 01/2022
1	Aneuploidy (Aneuploid) 01/2022
1	Venous Thromboembolism 01/2022
1	Breast Neoplasms (Breast Cancer) 12/2021
1	Adenocarcinoma 01/2020
1	Medulloblastoma 12/2019
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 05/2019
1	Hypersensitivity (Allergy) 07/2015

Drug/Important Bio-Agent (IBA)

8	DNA (Deoxyribonucleic Acid)IBA 06/2022 - 04/2013
5	Androgen Receptors (Androgen Receptor)IBA 01/2023 - 09/2014
4	Proteins (Proteins, Gene)FDA Link 03/2024 - 01/2017
4	Hormones (Hormone)IBA 01/2017 - 03/2015
3	RNA (Ribonucleic Acid)IBA 02/2024 - 01/2019
3	Cell-Free Nucleic AcidsIBA 06/2022 - 01/2020
2	ChromatinIBA 03/2024 - 03/2015
2	NucleotidesIBA 03/2024 - 01/2020
2	Transient Receptor Potential ChannelsIBA 02/2024 - 12/2020
2	AndrogensIBA 02/2024 - 01/2022
2	Circulating Tumor DNAIBA 01/2020 - 01/2020
2	Biomarkers (Surrogate Marker)IBA 01/2019 - 07/2015
2	abirateroneIBA 11/2015 - 09/2014
1	Interferon Type IIBA 03/2024
1	Phenobarbital (Luminal)FDA Link 03/2024
1	Vitamin A (Retinol)FDA LinkGeneric 03/2024
1	NF-kappa B (NF-kB)IBA 02/2024
1	Collagen Type I (Type I Collagen)IBA 02/2024
1	EpitopesIBA 01/2023
1	HLA Antigens (Human Leukocyte Antigens)IBA 01/2023
1	HLA-DR Antigens (HLA-DR)IBA 01/2023
1	transporter associated with antigen processing (TAP)IBA 01/2023
1	Histocompatibility Antigens Class IIIBA 01/2023
1	AntigensIBA 01/2023
1	HLA-B Antigens (HLA-B)IBA 01/2023
1	Histocompatibility Antigens Class IIBA 01/2023
1	SolutionsIBA 06/2022
1	brigatinibIBA 02/2022
1	lorlatinibIBA 02/2022
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2022
1	Harmine (Telepathine)IBA 01/2022
1	AC133 AntigenIBA 01/2022
1	activin AIBA 01/2022
1	RNA-Binding Proteins (RNA-Binding Protein)IBA 12/2021
1	CationsIBA 12/2020
1	CalciumIBA 12/2020
1	Messenger RNA (mRNA)IBA 11/2020
1	MicroRNAs (MicroRNA)IBA 11/2020
1	Indicators and Reagents (Reagents)IBA 01/2020
1	hydrogen sulfite (bisulfite)IBA 01/2020
1	Pemetrexed (MTA)FDA Link 05/2019
1	Cisplatin (Platino)FDA LinkGeneric 05/2019
1	ErbB Receptors (EGF Receptor)IBA 05/2019
1	Tyrosine Kinase InhibitorsIBA 05/2019
1	osimertinibIBA 05/2019
1	Aurora Kinase AIBA 01/2019
1	MLN 8237IBA 01/2019
1	ElementsIBA 01/2017
1	Amino Acids FDA Link 11/2015
1	PlatinumIBA 07/2015
1	Transcription Factors (Transcription Factor)IBA 03/2015
1	Prednisolone (Predate)FDA LinkGeneric 09/2014
1	Dexamethasone (Maxidex)FDA LinkGeneric 09/2014
1	GlucocorticoidsIBA 09/2014

Therapy/Procedure

7	Castration 01/2022 - 11/2015
6	Precision Medicine 02/2023 - 07/2015
6	Therapeutics 01/2022 - 08/2014
2	Drug Therapy (Chemotherapy) 01/2022 - 05/2019
1	Immunotherapy 01/2023